Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing - Test2 - elhamkhani - TriplyDB

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

http://www.wikidata.org/entity/Q24612248

about

The spectrum of SWI/SNF mutations, ubiquitous in human cancers The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?A landscape of driver mutations in melanoma Mutational heterogeneity in cancer and the search for new cancer-associated genes Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives Current challenges and novel treatment strategies in double hit lymphomas MEF2 transcription factors: developmental regulators and emerging cancer genes EZH2 in normal hematopoiesis and hematological malignancies Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas Next-generation prognostic assessment for diffuse large B-cell lymphoma Chemical probes of histone lysine methyltransferases Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma The Yin and Yang of Toll-like receptors in cancer The epigenetic basis of diffuse large B-cell lymphoma The genetic landscape of diffuse large B-cell lymphoma Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention SWI/SNF chromatin remodeling complexes and cancer Emerging patterns of somatic mutations in cancer Chromatin signatures of cancer Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review Structural Context of Disease-Associated Mutations and Putative Mechanism of Autoinhibition Revealed by X-Ray Crystallographic Analysis of the EZH2-SET Domain Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.Lymphoma: immune evasion strategies Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181 Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes AID targeting: old mysteries and new challenges Discovery and saturation analysis of cancer genes across 21 tumour types Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas Age-related clonal hematopoiesis associated with adverse outcomes An ImmunoChip study of multiple sclerosis risk in African Americans.Regulation of TGF-β signaling, exit from the cell cycle, and cellular migration through cullin cross-regulation: SCF-FBXO11 turns off CRL4-Cdt2.The genetic landscape of mutations in Burkitt lymphoma.PatternCNV: a versatile tool for detecting copy number changes from exome sequencing data.DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer.Integration of genomic data enables selective discovery of breast cancer drivers.

P2860

Q21090801-195909FC-31A9-4619-944B-1B88B1E95A80 Q24306032-4693F797-4A6F-4B5A-A180-57FFD05BC198 Q24596715-94F346B0-DD1D-4773-9018-20968FC36DD8 Q24597424-CCD33F31-753E-49C0-AC7E-F71F29AD5049 Q24603357-F96201BD-850C-487D-B7C3-59D1FF614FE6 Q24606956-302DD07D-3971-4E75-9CD5-44FEB2C34ED7 Q26744080-228D6AA4-D233-475A-A69A-FAD59D4F7312 Q26744441-E803F650-8195-4D26-BCB6-29AF525B452E Q26770385-F00FFD31-6C7E-4545-B2C7-3161297E007E Q26778515-C6B17B34-03C3-46B0-94FD-A0534A35B4EC Q26779821-A2B44D9C-2E9A-41FE-A5E7-676984D3C010 Q26782506-E6BF42BF-2944-4D0A-839A-4408D6406F43 Q26796428-9C44D399-8B6F-4E54-821C-06750CFD8010 Q26829218-368315B4-8E38-4B1B-BC93-4751883CCC9E Q26851166-5F0500CD-1CE3-4426-B478-C1CF2C42878B Q26851526-760BE072-423F-41BE-BEBB-1621BB040A4F Q26852288-7A64829B-AEA2-431F-BEA0-94EC60244E63 Q26866537-826A159F-6EAA-43CD-A1B1-C876B9CCFF49 Q26994739-56EA870E-6E25-4E13-8BF6-07928FF5155A Q26998657-0A6713A2-767E-4CC5-848D-8817C15985D3 Q27014126-6E508895-505A-4E8B-89C3-B2E70786859E Q27024162-D72B5D98-4DE4-4B75-AB5E-C7F39761F129 Q27304386-6B5A80CC-1D2D-409B-8295-01EADDE705F6 Q27681087-405F63DE-C1EB-4FCA-AFE4-9BEAB7C0BE3F Q27853005-F252D606-F840-4964-A393-7AE3EA53E169 Q28080705-8DED5A01-34AA-4770-A035-BD45E26E3B5D Q28082536-601E01EE-89A2-442B-96E2-FEA903CB8301 Q28115962-78C59B37-6AD0-4E24-A140-347DB8717722 Q28117437-D44917B9-FE35-4DAB-BCA2-379EBFF489AB Q28261895-DB982A98-51B3-4ABE-B566-9A70CDC23503 Q28265992-6A951DD9-A981-4F50-90D6-D1641A89C0A8 Q28305204-221D4D4A-BDAD-42E4-B804-E22FC3CE6B33 Q28305680-464DE654-8F45-4B69-9470-E2A350BA5575 Q28386602-DCE9DC79-7924-458F-BA0E-F6659B594E56 Q30300285-06224793-34A2-497F-8BB4-2D81374D6207 Q30411902-95547E75-A7D2-4995-96BC-81429122C548 Q30453771-813B5887-BAFD-46D3-B3E0-53911FEE3F76 Q30827643-27C9DDBD-5BB9-49EF-8BB8-C98271EE7FB9 Q30837199-7B01697D-BB9D-4BD1-91ED-62A0A137BAB7 Q30872438-C03432B8-6577-4102-9D7A-31CB7B66A0BB

P2860

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

http://www.wikidata.org/entity/Q24612248

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Discovery and prioritization o ...... BCL) by whole-exome sequencing

@ast

Discovery and prioritization o ...... BCL) by whole-exome sequencing

@en

Discovery and prioritization o ...... BCL) by whole-exome sequencing

@nl

type

label

Discovery and prioritization o ...... BCL) by whole-exome sequencing

@ast

Discovery and prioritization o ...... BCL) by whole-exome sequencing

@en

Discovery and prioritization o ...... BCL) by whole-exome sequencing

@nl

prefLabel

Discovery and prioritization o ...... BCL) by whole-exome sequencing

@ast

Discovery and prioritization o ...... BCL) by whole-exome sequencing

@en

Discovery and prioritization o ...... BCL) by whole-exome sequencing

@nl

P1433

Q24612248-59B45DE8-EC6B-4F93-AE56-71112996BDE4

P1476

Q24612248-A0C7353F-744D-4BE4-A83F-010D37949D01

P2093

Q24612248-366B6A39-2408-433A-8876-FCE0EEFC5574

Q24612248-3A459D77-148E-4A4D-A7CC-0DF07F3E52A8

Q24612248-458106D4-487E-4021-AC8A-5EB5D43D79B7

Q24612248-47AB0BAE-4ADD-416F-9BA3-5CA7031BE1DB

Q24612248-586AF4A4-09E5-4B2E-A8D9-9757441E1E25

Q24612248-7A7DEA29-0B4B-4A3A-BAF4-4F5F15C244CD

Q24612248-7DD1116C-02E9-43E8-8750-B6B853687743

Q24612248-86AF14DD-54DC-4DD8-A2EE-2868C8151421

Q24612248-9E06BA98-521B-4A8C-A0F3-0894A02C7CEF

Q24612248-B1CB8E51-24AF-4591-9D25-B00F859F5425

P2860

Q24612248-05DC9D97-E6AF-4809-A378-52770682F016

Q24612248-24635CD2-A952-4619-8134-D49902090D98

Q24612248-2522470F-BACB-4BF3-BD60-84F53E48670D

Q24612248-2E017B72-9BDB-4312-8A2D-C4A6F2FF0668

Q24612248-39AE5420-1B7D-47FD-9053-DECC84FC6045

Q24612248-3C144528-9011-4E9A-AC64-A41460E5CB11

Q24612248-3E41FF9A-5709-489B-B5F2-ABDE7B5E075F

Q24612248-3EBE7413-EA07-4251-A1A9-F8761B3F2AEA

Q24612248-42E25E05-EF40-4FA8-814D-0247F9C3565A

Q24612248-49BDBBCD-E9F3-49AC-84B6-4B2E5208289E

P304

Q24612248-D719C840-E241-4E64-95BC-BCC259C0C131

P31

Q24612248-6506C419-D10A-4619-BEDB-53C21FF114F3

P3181

Q24612248-002B0A2D-42B9-4766-8BA9-2A0B7DA4E322

P356

Q24612248-5765AD85-3754-49FA-9429-B50A07C47531

P407

Q24612248-52C3E6F1-6F78-4526-ABA9-B85711FADF12

P433

Q24612248-6D9804F8-028D-471E-B9F7-B704F989BBF4

P478

Q24612248-FE4D6312-6162-499B-9017-45E298A25C71

P50

Q24612248-068DB927-CAB3-43C0-B819-8E4F53296C18

Q24612248-09E74F37-6027-4796-8A6B-3E92A854E1FC

Q24612248-1630FD6E-A7C4-41C4-BDBD-AB7D3805B443

Q24612248-1D778056-C2C9-4EAE-B809-D76B29129E31

Q24612248-358E81BB-2705-41F8-94CF-9C2E9E3B091F

Q24612248-3B815A20-8BAD-4A1D-A689-79DB11DDCCB9

Q24612248-450A012E-8DC7-4307-9D36-E1FB8B7860ED

Q24612248-61410B4B-185D-4FEE-9D26-EB16CC145A5E

Q24612248-64BE3372-3058-459E-8C7B-F51624596FE6

Q24612248-A8803439-357B-4BA2-A032-4E5CDF25AF09

P577

Q24612248-21594665-AA97-4161-9CA8-06F31717CD0B

P5875

Q24612248-1B1D4BC9-9481-41C9-A417-E1247C811A64

P698

Q24612248-7F087005-1425-4CBB-9F4A-C8F7A13FFE2F

P932

Q24612248-51390A96-5C8F-48AB-BA52-67F4CFD69A8F

P3181

P356

PNAS.1121343109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Discovery and prioritization o ...... BCL) by whole-exome sequencing

@en

P2093

Ahmet Dogan

http://www.w3.org/2001/XMLSchema#string

Angela Schwarz-Cruz y Celis

http://www.w3.org/2001/XMLSchema#string

Birgit Knoechel

http://www.w3.org/2001/XMLSchema#string

Bjoern Chapuy

http://www.w3.org/2001/XMLSchema#string

Chandra S Pedamallu

http://www.w3.org/2001/XMLSchema#string

Claudia Rangel-Escareño

http://www.w3.org/2001/XMLSchema#string

Enrique Hernández-Lemus

http://www.w3.org/2001/XMLSchema#string

Ivan Imaz-Rosshandler

http://www.w3.org/2001/XMLSchema#string

Jens G Lohr

http://www.w3.org/2001/XMLSchema#string

Joonil Jung

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome

Initial genome sequencing and analysis of multiple myeloma

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

Disruption of a new X linked gene highly expressed in brain in a family with two mentally retarded males

MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas

P304

3879-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

686634

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.1121343109

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Nicolas Stransky

Akinyemi I Ojesina

Alfredo Hidalgo-Miranda

P577

2012-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221841080

http://www.w3.org/2001/XMLSchema#string

P698

22343534

http://www.w3.org/2001/XMLSchema#string

P932

3309757

http://www.w3.org/2001/XMLSchema#string